Financial Statements — MRNA
Balance Sheet
(in billions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Cash & Equivalents | 1.91 | 1.13 | 1.28 | 1.62 | 1.64 | 2.48 | 2.05 | 2.93 | 3.80 | 3.44 | 3.03 | 2.87 | 5.05 | 5.55 | 5.60 | 5.44 |
| Accounts Receivable | 0.07 | 1.05 | 0.04 | 0.08 | 1.56 | 0.16 | 0.14 | 1.87 | 0.23 | 1.11 | 2.70 | 2.69 | 3.17 | 3.14 | 2.02 | 3.21 |
| Inventory | 0.15 | 0.33 | 0.24 | 0.13 | 0.41 | 0.40 | 0.30 | 0.49 | 0.72 | 0.73 | 2.08 | 1.92 | 1.94 | 0.97 | 0.64 | 0.49 |
| Total Current Assets | 5.77 | 6.60 | 6.17 | 6.77 | 9.67 | 9.66 | 9.60 | 10.80 | 10.60 | 12.12 | 14.30 | 13.56 | 16.35 | 13.43 | 10.97 | 11.70 |
| Property, Plant & Equipment | 2.09 | 2.13 | 2.17 | 2.21 | 2.38 | 2.20 | 2.06 | 1.95 | 2.28 | 2.02 | 2.02 | 1.32 | 1.34 | 0.85 | 0.79 | 0.37 |
| Goodwill | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | -- | -- | -- | -- | -- | -- |
| Intangible Assets | 0.12 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | -- | -- | -- | -- | -- | -- |
| Total Non-current Assets* | 5.72 | 5.54 | 5.84 | 5.94 | 6.14 | 6.02 | 7.13 | 8.65 | 11.29 | 12.00 | 11.76 | 12.48 | 11.26 | 7.50 | 5.18 | 0.99 |
| Total Assets | 11.49 | 12.14 | 12.01 | 12.70 | 15.80 | 15.68 | 16.73 | 19.45 | 21.88 | 24.13 | 26.06 | 26.04 | 27.61 | 20.92 | 16.15 | 12.69 |
| Accounts Payable | 0.16 | 0.27 | 0.18 | 0.23 | 0.37 | 0.28 | 0.18 | 0.49 | 0.31 | 0.39 | 0.33 | 0.18 | 0.20 | 0.09 | 0.08 | 0.01 |
| Total Current Liabilities | 2.40 | 1.68 | 1.57 | 1.60 | 2.20 | 2.36 | 2.38 | 4.39 | 3.12 | 3.50 | 6.81 | 6.81 | 9.24 | 9.96 | 8.84 | 8.44 |
| Long-term Debt | 0.59 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-current Liabilities* | 1.69 | 1.12 | 1.04 | 1.03 | 1.68 | 1.61 | 1.53 | 1.61 | 1.81 | 1.76 | 1.26 | 1.25 | 1.30 | 0.84 | 0.61 | 0.42 |
| Total Liabilities | 4.08 | 2.81 | 2.61 | 2.64 | 3.88 | 3.97 | 3.91 | 6.00 | 4.93 | 5.26 | 8.06 | 8.06 | 10.53 | 10.80 | 9.45 | 8.86 |
| Retained Earnings | 5.88 | 8.05 | 8.25 | 9.07 | 11.17 | 11.15 | 12.43 | 13.39 | 17.02 | 18.40 | 16.86 | 15.81 | 13.62 | 5.09 | 1.76 | (1.02) |
| Total Stockholder Equity | 7.41 | 9.33 | 9.40 | 10.07 | 11.93 | 11.71 | 12.82 | 13.46 | 16.95 | 18.86 | 17.99 | 17.99 | 17.08 | 10.12 | 6.70 | 3.84 |
* Derived from reported values
Income Statement
(in billions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 |
|---|
| Total Revenue | 0.39 | 0.68 | 1.02 | 0.14 | 0.11 | 0.97 | 1.86 | 0.24 | 0.17 | 2.81 | 1.83 | 0.34 | 1.86 | 5.08 | 3.36 | 4.75 | 6.07 | 7.21 | 4.97 | 4.35 |
| Cost of Revenue | 0.96 | 0.45 | 0.21 | 0.12 | 0.09 | 0.74 | 0.51 | 0.12 | 0.10 | 0.93 | 2.24 | 0.73 | 0.79 | 1.92 | 1.10 | 1.38 | 1.02 | 0.95 | 0.72 | 0.75 |
| Gross Profit | (0.57) | 0.23 | 0.81 | 0.02 | 0.02 | 0.23 | 1.35 | 0.13 | 0.07 | 1.88 | (0.41) | (0.39) | 1.07 | 3.17 | 2.26 | 3.37 | 5.05 | 6.26 | 4.25 | 5.35 |
| Research & Development | 0.65 | 0.78 | 0.80 | 0.70 | 0.86 | 1.12 | 1.14 | 1.22 | 1.06 | 1.41 | 1.16 | 1.15 | 1.13 | 1.21 | 0.82 | 0.71 | 0.55 | 0.65 | 0.52 | 0.42 |
| Selling, General & Admin | 0.17 | 0.31 | 0.27 | 0.23 | 0.21 | 0.35 | 0.28 | 0.27 | 0.27 | 0.47 | 0.44 | 0.33 | 0.31 | 0.38 | 0.28 | 0.21 | 0.27 | 0.20 | 0.17 | 0.12 |
| Total Operating Expenses | 0.82 | 1.08 | 1.07 | 0.93 | 1.07 | 1.47 | 1.42 | 1.49 | 1.34 | 1.88 | 1.60 | 1.48 | 1.44 | 1.59 | 1.10 | 0.92 | 0.82 | 0.85 | 0.69 | 1.02 |
| Operating Income | (1.39) | (0.86) | (0.26) | (0.91) | (1.05) | (1.25) | (0.07) | (1.36) | (1.27) | 0.01 | (2.01) | (1.87) | (0.37) | 1.58 | 1.17 | 2.45 | 4.23 | 5.41 | 3.56 | 3.06 |
| Pretax Income | (1.33) | (0.80) | (0.19) | (0.82) | (0.96) | (1.18) | 0.02 | (1.28) | (1.16) | 0.07 | (1.96) | (1.75) | (0.30) | 1.66 | 1.22 | 2.47 | 4.23 | 5.41 | 3.55 | 3.06 |
| Tax Provision | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | (0.06) | 0.01 | 0.00 | 0.01 | (0.15) | 1.67 | (0.37) | (0.38) | 0.19 | 0.17 | 0.28 | 0.57 | 0.54 | 0.22 | 0.28 |
| Net Income | (1.34) | (0.83) | (0.20) | (0.82) | (0.97) | (1.12) | 0.01 | (1.28) | (1.17) | 0.22 | (3.63) | (1.38) | 0.08 | 1.47 | 1.04 | 2.20 | 3.66 | 4.87 | 3.33 | 2.78 |
| Basic EPS | (3.40) | (2.10) | (0.51) | (2.13) | (2.52) | (2.91) | 0.03 | (3.33) | (3.07) | 0.62 | (9.53) | (3.62) | 0.20 | 3.95 | 2.67 | 5.55 | 9.09 | 12.06 | 8.27 | 6.93 |
| Diluted EPS | (3.40) | (2.10) | (0.51) | (2.13) | (2.52) | (2.91) | 0.03 | (3.33) | (3.07) | 0.63 | (9.53) | (3.62) | 0.19 | 3.77 | 2.53 | 5.24 | 8.58 | 11.29 | 7.70 | 6.46 |
Cash Flow Statement
(in billions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 |
|---|
| Operating Cash Flow | (0.63) | 0.93 | (0.85) | (0.92) | (1.04) | 0.83 | (1.57) | (1.27) | (0.99) | 0.62 | (1.60) | (0.91) | (1.23) | 1.66 | 0.25 | 0.30 | 2.76 | 3.31 | 3.28 | 4.06 |
| Capital Expenditures | 0.06 | 0.04 | 0.03 | 0.00 | 0.12 | 0.52 | 0.15 | 0.18 | 0.20 | 0.22 | 0.14 | 0.23 | 0.11 | 0.09 | 0.09 | 0.09 | 0.13 | 0.12 | 0.10 | 0.03 |
| Free Cash Flow* | (0.69) | 0.89 | (0.88) | (0.92) | (1.15) | 0.30 | (1.72) | (1.46) | (1.18) | 0.40 | (1.74) | (1.15) | (1.34) | 1.57 | 0.16 | 0.22 | 2.63 | 3.19 | 3.18 | 4.03 |
| Investing Cash Flow | (0.08) | (0.05) | 0.70 | 0.56 | 0.73 | (0.54) | 0.72 | 1.65 | 0.12 | (0.54) | 0.79 | 1.94 | 2.01 | (1.05) | 0.95 | (1.15) | (3.92) | (1.14) | (3.33) | (3.88) |
| Financing Cash Flow | 0.02 | 0.58 | -0.00 | 0.01 | 0.00 | -0.00 | 0.01 | 0.03 | 0.01 | (0.11) | (0.06) | (0.67) | (0.54) | (0.44) | (1.04) | (1.33) | (0.64) | (0.87) | -0.00 | (0.02) |
* Derived from reported values
